These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38762169)

  • 1. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD.
    Gawrieh S; Vilar-Gomez E; Wilson LA; Pike F; Kleiner DE; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Kowdley KV; Hameed B; Tonascia J; Loomba R; Sanyal AJ; Chalasani N;
    J Hepatol; 2024 Oct; 81(4):600-608. PubMed ID: 38762169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.
    Zhou XD; Kim SU; Yip TC; Petta S; Nakajima A; Tsochatzis E; Boursier J; Bugianesi E; Hagström H; Chan WK; Romero-Gomez M; Calleja JL; de Lédinghen V; Castéra L; Sanyal AJ; Goh GB; Newsome PN; Fan J; Lai M; Fournier-Poizat C; Lee HW; Wong GL; Armandi A; Shang Y; Pennisi G; Llop E; Yoneda M; Saint-Loup M; Canivet CM; Lara-Romero C; Gallego-Duràn R; Asgharpour A; Teh KK; Mahgoub S; Chan MS; Lin H; Liu WY; Targher G; Byrne CD; Wong VW; Zheng MH;
    Gut; 2024 Oct; 73(11):1883-1892. PubMed ID: 39089860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
    Thorhauge KH; Semmler G; Johansen S; Lindvig KP; Kjærgaard M; Hansen JK; Torp N; Hansen CD; Andersen P; Hofer BS; Gu W; Israelsen M; Mandorfer M; Reiberger T; Trebicka J; Thiele M; Krag A;
    J Hepatol; 2024 Jul; 81(1):23-32. PubMed ID: 38428644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
    Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Gutierrez ML; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Ahumada A; Bauer DJM; Mauz JB; Casanova-Cabral M; Gschwantler M; Russo FP; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M;
    J Hepatol; 2024 Jul; 81(1):76-83. PubMed ID: 38521170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.
    Hayashi H; Kamada Y; Fujii H; Takahashi H; Oeda S; Iwaki M; Kawaguchi T; Tomita E; Yoneda M; Tokushige A; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T;
    Ultrasound Med Biol; 2023 Jul; 49(7):1658-1664. PubMed ID: 37120329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.
    Boursier J; Hagström H; Ekstedt M; Moreau C; Bonacci M; Cure S; Ampuero J; Nasr P; Tallab L; Canivet CM; Kechagias S; Sánchez Y; Dincuff E; Lucena A; Roux M; Riou J; Trylesinski A; Romero-Gomez M
    J Hepatol; 2022 May; 76(5):1013-1020. PubMed ID: 35063601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD.
    Gidener T; Dierkhising RA; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Yin M; Allen AM
    Hepatology; 2023 Jan; 77(1):268-274. PubMed ID: 35642504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease.
    Yu H; Huang Y; Li M; Jiang H; Yang B; Xi X; Smayi A; Wu B; Yang Y
    J Gastroenterol Hepatol; 2024 Oct; 39(10):2169-2181. PubMed ID: 38946401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
    Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
    J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD.
    Pennisi G; Enea M; Pandolfo A; Celsa C; Antonucci M; Ciccioli C; Infantino G; La Mantia C; Parisi S; Tulone A; Di Marco V; Craxì A; Cammà C; Petta S
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1293-1302.e5. PubMed ID: 35842119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
    Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study.
    Jachs M; Odriozola A; Turon F; Moga L; Téllez L; Fischer P; Saltini D; Kwanten WJ; Grasso M; Llop E; Mendoza YP; Armandi A; Thalhammer J; Pardo C; Colecchia A; Ravaioli F; Maasoumy B; Laleman W; Presa J; Schattenberg JM; Berzigotti A; Calleja JL; Calvaruso V; Francque S; Schepis F; Procopet B; Albillos A; Rautou PE; García-Pagán JC; Puente Á; Fortea JI; Reiberger T; Mandorfer M; ;
    Lancet Gastroenterol Hepatol; 2024 Dec; 9(12):1111-1120. PubMed ID: 39326431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients.
    Wong YJ; Chen VL; Abdulhamid A; Tosetti G; Navadurong H; Kaewdech A; Cristiu J; Song M; Devan P; Tiong KLA; Neo JE; Prasoppokakorn T; Sripongpun P; Stedman CAM; Treeprasertsuk S; Primignani M; Ngu JH; Abraldes JG
    Hepatology; 2024 Apr; ():. PubMed ID: 38630497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
    Papatheodoridi M; Hiriart JB; Lupsor-Platon M; Bronte F; Boursier J; Elshaarawy O; Marra F; Thiele M; Markakis G; Payance A; Brodkin E; Castera L; Papatheodoridis G; Krag A; Arena U; Mueller S; Cales P; Calvaruso V; de Ledinghen V; Pinzani M; Tsochatzis EA
    J Hepatol; 2021 May; 74(5):1109-1116. PubMed ID: 33307138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Fibrosis-4, liver-stiffness measurement, and Fibroscan-AST score to predict liver-related outcomes in nonalcoholic fatty liver disease.
    Wong YJ; Urias E; Song MW; Goyal T; Tay WX; Han NX; Loo JH; Qiu TY; Wijarnpreecha K; Chan YH; Chen VL
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37738409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD.
    Gidener T; Ahmed OT; Larson JJ; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Yin M; Allen AM
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1915-1924.e6. PubMed ID: 33010409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
    Semmler G; Yang Z; Fritz L; Köck F; Hofer BS; Balcar L; Hartl L; Jachs M; Stopfer K; Schedlbauer A; Neumayer D; Maurer J; Müllner-Bucsics T; Simbrunner B; Scheiner B; Trauner M; Mandorfer M; Reiberger T; Bauer DJM
    Gastroenterology; 2023 Oct; 165(4):1041-1052. PubMed ID: 37442301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
    Siddiqui MS; Vuppalanchi R; Van Natta ML; Hallinan E; Kowdley KV; Abdelmalek M; Neuschwander-Tetri BA; Loomba R; Dasarathy S; Brandman D; Doo E; Tonascia JA; Kleiner DE; Chalasani N; Sanyal AJ;
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):156-163.e2. PubMed ID: 29705261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis.
    Corpechot C; Carrat F; Gaouar F; Chau F; Hirschfield G; Gulamhusein A; Montano-Loza AJ; Lytvyak E; Schramm C; Pares A; Olivas I; Eaton JE; Osman KT; Dalekos G; Gatselis N; Nevens F; Cazzagon N; Zago A; Russo FP; Abbas N; Trivedi P; Thorburn D; Saffioti F; Barkai L; Roccarina D; Calvaruso V; Fichera A; Delamarre A; Medina-Morales E; Bonder A; Patwardhan V; Rigamonti C; Carbone M; Invernizzi P; Cristoferi L; van der Meer A; de Veer R; Zigmond E; Yehezkel E; Kremer AE; Deibel A; Dumortier J; Bruns T; Große K; Pageaux GP; Wetten A; Dyson J; Jones D; Chazouillères O; Hansen B; de Lédinghen V;
    J Hepatol; 2022 Dec; 77(6):1545-1553. PubMed ID: 35777587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
    Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
    Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.